Antipsychotic drugs in dementia: what should be made of the risks?

JAMA. 2005 Oct 19;294(15):1963-5. doi: 10.1001/jama.294.15.1963.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Cerebrovascular Disorders / chemically induced
  • Dementia / drug therapy*
  • Dementia / mortality
  • Humans
  • Risk Assessment

Substances

  • Antipsychotic Agents